Tag: Dopamine precursor

  • L-DOPA (Levodopa)

    Dopamine precursor

    The immediate precursor of dopamine and the principal pharmacological treatment for Parkinson disease, FDA-approved in combination with carbidopa.

    Abstract

    L-DOPA (levodopa, L-3,4-dihydroxyphenylalanine; CAS 59-92-7; molecular formula C9H11NO4; molecular weight 197.19) is the immediate precursor of dopamine in the catecholamine biosynthesis pathway. The compound is FDA-approved in combination with carbidopa (Sinemet) or benserazide for Parkinson disease. L-DOPA is the principal symptomatic treatment for Parkinson disease and remains the gold standard despite long-term complications including motor fluctuations and dyskinesia. The compound is also extracted naturally from Mucuna pruriens.

    FOR RESEARCH USE ONLY. Not for medical, diagnostic, or therapeutic purposes. Not for human or animal consumption. All information is provided for research and educational purposes only.